View: |
Part 1: Document Description
|
Citation |
|
---|---|
Title: |
Pfizer-BioNTech(BNT162b2) vaccine effectiveness against symptomatic laboratory-confirmed COVID-19 infection among outpatients in sentinel sites, Lebanon, July-December 2021 |
Identification Number: |
doi:10.7910/DVN/K7K5LB |
Distributor: |
Harvard Dataverse |
Date of Distribution: |
2024-04-10 |
Version: |
1 |
Bibliographic Citation: |
chaito, lina, 2024, "Pfizer-BioNTech(BNT162b2) vaccine effectiveness against symptomatic laboratory-confirmed COVID-19 infection among outpatients in sentinel sites, Lebanon, July-December 2021", https://doi.org/10.7910/DVN/K7K5LB, Harvard Dataverse, V1 |
Citation |
|
Title: |
Pfizer-BioNTech(BNT162b2) vaccine effectiveness against symptomatic laboratory-confirmed COVID-19 infection among outpatients in sentinel sites, Lebanon, July-December 2021 |
Identification Number: |
doi:10.7910/DVN/K7K5LB |
Authoring Entity: |
chaito, lina (lebanese ministry of public health) |
Distributor: |
Harvard Dataverse |
Access Authority: |
chaito, lina |
Depositor: |
chaito, lina |
Date of Deposit: |
2024-04-10 |
Holdings Information: |
https://doi.org/10.7910/DVN/K7K5LB |
Study Scope |
|
Keywords: |
Medicine, Health and Life Sciences, pfizer vaccine effectiveness |
Abstract: |
This database contains minimal raw data collected from outpatients with respiratory symptoms visiting influenza like illness/ COVID-19 like illness surveillance sentinel sites in Lebanon during (July-December 2021). It includes information on socio-demographic characteristics, general health status, COVID-19 vaccination and practice on non-pharmaceutical interventions. |
Methodology and Processing |
|
Sources Statement |
|
Data Access |
|
Other Study Description Materials |
|
Label: |
VE study-dataset.xls |
Text: |
This database contains minimal raw data collected from outpatients with respiratory symptoms visiting influenza like illness/ COVID-19 like illness surveillance sentinel sites in Lebanon during (July-September 2021). It includes information on socio-demographic characteristics, general health status, COVID-19 vaccination and practice on non-pharmaceutical interventions. |
Notes: |
application/vnd.ms-excel |